Fatal hepatitis associated with isoflurane exposure and CYP2A6 autoantibodies

Anesthesiology

Volumn 95, Issue 2, 2001, Pages 551-553

  Martin, Jackie L ^a,b   Keegan, Mark T ^c   Vasdev, Gurinder M S ^b   Nyberg, Scott L ^b   Bourdi, Mohammed ^b   Pohl, Lance R ^b   Plevak, David J ^b,d  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c Division of Critical Care

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CYTOCHROME P450 2A6; ENFLURANE; ISOFLURANE; PARACETAMOL;

ADULT; ANTIBODY TITER; ARTICLE; CASE REPORT; CONTROLLED STUDY; DRUG EXPOSURE; DRUG METABOLISM; DRUG SENSITIZATION; FATALITY; FEMALE; HEPATITIS; HUMAN; PRIORITY JOURNAL;

EID: 0034906520     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200108000-00043     Document Type: Article

References (30)

1. Biotransformation of halothane, enflurane, isoflurane, and desflurane to trifluoroacetylated liver proteins: Association between protein acylation and hepatic injury
2. Human cytochrome P450 2E1 is a major autoantigen associated with halothane hepatitis
3. Oxidation of acetaminophen to its toxic quinone imine and nontoxic catechol metabolites by baculovirus-expressed and purified human cytochromes P450 2E1 and 2A6
4. Antibody assays for the detection of patients sensitized to halothane
5. Summary of the National Halothane Study: Possible associations between halothane anesthesia and postoperative hepatic necrosis
6. UDP-Glucose: Glycoprotein glucosyltransferase associates with endoplasmic reticulum chaperones and its activity is decreased in vivo by the inhalation anesthetic halothane
7. Metabolic basis for a drug hypersensitivity: Antibodies in sera from patients with halothane hepatitis recognize liver neoantigens that contain the trifluoroacetyl group derived from halothane
8. Mechanisms, chemical structures and drug metabolism
9. The organ toxicity of inhaled anesthetics
10. Enflurane hepatotoxicity: A clinicopathologic study of 24 cases
11. Hepatotoxicity and death following two enflurane anesthetics
12. A report of hepatic necrosis and death following isoflurane anesthesia
13. Fulminant hepatic failure after repeated exposure to isoflurane anesthesia: A case report
14. Isoflurane hepatotoxicity: A case report and review of the literature
15. Hepatotoxicity after desflurane anesthesia
16. Halothane hepatitis patients have serum antibodies that react with protein disulfide isomerase
17. Association of anti-58 kDa endoplasmic reticulum antibodies with halothane hepatitis
18. Serum antibodies from halothane hepatitis patients react with rat endoplasmic reticulum protein ERp72
19. The human hepatic cytochromes P450 involved in drug metabolism
20. Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P450 that hydroxylates the drug
21. Anti-liver endoplasmic reticulum autoantibodies are directed against a human cytochrome P450 1A2: A specific marker of dihydralazine-induced hepatitis
22. Antibodies against human cytochrome P450 db 1 in autoimmune hepatitis type II
23. Two cytochromes P 450 are major hepatocellular autoantigens in autoimmune polyglandular syndrome type 1
24. Cytochrome P450 2E1 is a cell surface autoantigen in halothane hepatitis
25. Cytochrome P4502E1 is the principal catalyst of human oxidative halothane metabolism in vitro
26. Halothane-induced liver injury in outbred guinea pigs: Role of trifluoroacetylated protein adducts in animal susceptibility
27. Enflurane metabolism produces covalently bound liver adducts recognized by antibodies from patients with halothane hepatitis
28. Enflurane hepatitis: A report of a case with a previous history of halothane hepatitis
29. Suspected isoflurane hepatitis in an obese patient with a history of halothane hepatitis
30. Halothane hepatitis 28 years after primary exposure